[Effects of mitiglinide in treatment of impaired glucose tolerance].
Katahira
Hiroshi
H
Third Department of Internal Medicine, Kyorin University School of Medicine.
Ishida
Hitoshi
H
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D006943:Hyperglycemia / Q000150:complications / Q000188:drug therapy*; D007004:Hypoglycemic Agents / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use*; D007211:Indoles / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use*; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D054833:Isoindoles; D019518:Postprandial Period; D015221:Potassium Channels / Q000187:drug effects; D013268:Stimulation, Chemical
D007004:Hypoglycemic Agents; D007211:Indoles; D007328:Insulin; D054833:Isoindoles; D015221:Potassium Channels; D000255:Adenosine Triphosphate; C087255:mitiglinide